Global PET Nuclear Medicine Market By Type (F-18, Rb-82, Others), Application (Oncology, Cardiology, Neurology, Other PET Applications), Procedure (Diagnostic Procedures, Therapeutic Procedures), End User (Hospitals and Diagnostic Centers, Research Institutes), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2027
PET nuclear medicine market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 2.9 billion by 2027 growing at a CAGR of 8.0% in the above-mentioned forecast period. Increasing awareness among the people regarding the benefits of PET nuclear medicine which will further bring various opportunities for the growth of the market.
Surging volume of patients suffering from cardiovascular diseases, rising number of applications of radiopharmaceuticals, increasing preferences towards accurate diagnostic method, rising initiatives to reduce the demand supply gap of Mo99 are some of the factors which will likely to enhance the growth of the PET nuclear medicine market in the forecast period of 2020-2027. On the other hand, rising usages of radiopharmaceuticals in neurological applications along with multilateral supply agreements between countries which will further bring ample opportunities for the growth of the PET nuclear medicine market in the above mentioned forecast period.
High cost of procedure along with imposition of stringent regulations are acting as market restraints for the growth of the PET nuclear medicine in the above mentioned forecast period. Short life spam of radiopharmaceuticals which will become the biggest challenge for the growth of the market.
This PET nuclear medicine market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on PET nuclear medicine market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global PET Nuclear Medicine Market Scope and Market Size
PET nuclear medicine market is segmented on the basis of type, application, procedure, and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on type, PET nuclear medicine market is segmented into F-18, Rb-82, and others.
- On the basis of application, PET nuclear medicine market is segmented into oncology, cardiology, neurology, and other PET applications
- Based on procedure, PET nuclear medicine market is segmented into diagnostic procedures, and therapeutic procedures. Diagnostic procedures have been further segmented into SPECT procedures, and PET procedures. Therapeutic procedures have been further segmented into Beta emitter procedures, alpha emitter procedures, and brachytherapy procedures.
- PET nuclear medicine market has also been segmented based on the end user into hospitals and diagnostic centers, and research institutes.
PET Nuclear Medicine Market Country Level Analysis
PET nuclear medicine market is analysed and market size insights and trends are provided by country, type, application, procedure, and end user as referenced above.
The countries covered in the PET nuclear medicine market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the PET nuclear medicine market due to the adoption of the advanced technologies along with prevalence of funds for the research and development activities, while Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2020 to 2027 due to the rising awareness among the people regarding the benefits of nuclear medicine and growing number of geriatric population.
The country section of the PET nuclear medicine market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
PET nuclear medicine market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for PET nuclear medicine market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the PET nuclear medicine market. The data is available for historic period 2010 to 2018.
Competitive Landscape and PET Nuclear Medicine Market Share Analysis
PET nuclear medicine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to PET nuclear medicine market.
The major players covered in the PET nuclear medicine market report are Cardinal Health., Curium, GENERAL ELECTRIC COMPANY, Lantheus Medical Imaging, Inc., Bayer AG, Bracco Diagnostic Inc., Eczacıbaşı-Monrol, Nordion (Canada) Inc., Advancing Nuclear Medicine, NTP, NorthStar Medical Technologies., Eckert & Ziegler., Jubilant DraxImage, Inc., PharmaLogic Holdings Corp., Institute of Isotopes Co., Ltd,, first Beijing International Pharmaceutical Technology Co., Ltd., Isotopia Molecular Imaging Limited, SHINE Medical Technologies, LLC, Global Medical Solutions, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global PET Nuclear Medicine Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.